What is OFEV? \u2022 OFEV is a prescription medicine used to treat people with a lung disease called idiopathic pulmonary fibrosis (IPF). \u2022 It is not known if OFEV is safe and effective in children. Active ingredient: nintedanib. Inactive ingredients: Fill Material: triglycerides, hard fat, lecithin. Capsule Shell: gelatin, glycerol, titanium dioxide, red ferric oxide, yellow ferric oxide, black ink.<\/p>\n
If nintedanib capsules are not yet approved or available in your area, you may request its price in India under a specific brand name through IPN. For assistance and guidance, you can contact us by providing complete details. Our pharmaceutical expert will help you find a suitable and practical solution to your query. To receive comprehensive support, please call us at +91 9891 296 838 (Mr. Tarun) \/ +91 9811 747 774 (Mr. Neeraj).<\/p>\n
OFEV is a kinase inhibitor indicated for the treatment of idiopathic pulmonary fibrosis (IPF).<\/p>\n
Approval Date: 2014 If you have a prescription from a Registered Medical Practitioner (RMP),\u00a0IPN<\/a> in Delhi can assist you in obtaining access to genuine medication.\u00a0 Our professional will provide you with a step-by-step guide on how to legally and safely import \u201cnintedanib capsules\u201d based on the information you provide.<\/p>\n
\nProprietary Name: On Request
\nActive Ingredient(s):\u00a0 nintedanib capsules
\nDosage Forms And Strengths: Capsules: 150 mg and 100 mg
\nCompany: Boehringer Ingelheim Pharmaceuticals, Inc.
\nCurrent indications: idiopathic pulmonary fibrosis (IPF).
\nMedicine Approved By: \u2013<\/strong>\u00a0European Medical Agency (EMA), Food and Drug Administration (FDA), Health Canada, Therapeutic Goods Administration (TGA), Medsafe (NZ)
\nSummary of FDA approved use on approval date:<\/strong>\u00a0Click Here<\/a>
\n(see Drugs@FDA for complete indication)<\/p>\nAccess the best support services globally<\/h4>\n